WORLDSymposium™ 2027 to Honor Global Leaders in Clinical Research, Innovation, and Patient Advocacy
The 23rd Annual WORLDSymposium™ will be held January 31–February 4, 2027, in San Diego, California, USA. MINNEAPOLIS,
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.
![]()
The 23rd Annual WORLDSymposium™ will be held January 31–February 4, 2027, in San Diego, California, USA.
MINNEAPOLIS, MN, UNITED STATES, November 16, 2026 /EINPresswire.com/ — WORLDSymposium 2027 will recognize three distinguished individuals whose leadership and vision have advanced the understanding, treatment, and advocacy of lysosomal diseases. The awards will be presented during the 23rd annual WORLDSymposium, January 31–February 4, 2027, at the Manchester Grand Hyatt San Diego. Registration is now open for this premier international scientific meeting.
Catalyst Award
The 2027 Catalyst Award honors Karen Pignet, a biotech entrepreneur dedicated to advancing gene therapies for rare diseases. Following her daughter’s diagnosis with Sanfilippo syndrome, Ms. Pignet founded Lysogene and led an investigational gene therapy for Sanfilippo syndrome type A into an international Phase III clinical trial. She then founded Blue Daisy, a nonprofit organization that took over the program to bring the trial to completion. Her journey reflects a mother’s determination and an entrepreneur’s ability to mobilize people and resources to catalyze progress for patients and their families.
Roscoe O. Brady Award
WORLDSymposium is pleased to announce Cynthia J. Tifft, MD, PhD, as the recipient of the 2027 Roscoe O. Brady Award. A Senior Clinician and Deputy Clinical Director at the National Human Genome Research Institute, Dr. Tifft directs the Pediatric Undiagnosed Diseases Program, where she has coordinated the evaluation of nearly 600 children whose diagnoses long eluded the medical community. Her natural history research in glycosphingolipid and glycoprotein disorders, and the first-in-human gene therapy trial she and her team launched in 2019 for Type I and Type II GM1 gangliosidosis, have expanded both the understanding of these conditions and the possibilities for treating them.
Patient Advocate Leader (PAL) Award
Daniel Lewi, Co-founder and CEO of the Cure & Action for Tay-Sachs (CATS) Foundation, will receive the 2027 Patient Advocate Leader (PAL) Award. A rare-disease parent, Mr. Lewi established the UK charity in 2011 and has grown it into an internationally recognized patient organization. Through patient registries, support for clinical research, and collaboration across the European and global GM2 gangliosidoses community, he has worked to embed the patient voice throughout therapeutic development for Tay-Sachs and Sandhoff disease.
Looking Ahead: Late-Breaking Science
In addition to these award recognitions, WORLDSymposium 2027 will feature a Late-Breaking Science session highlighting the most current discoveries and clinical advances in lysosomal research. The Call for Late-Breaking Abstracts is open through December 1, 2026, and offers investigators an opportunity to share emerging data with an international audience of scientists, clinicians, and patient advocates.
Attend in San Diego
Award honorees will be formally recognized during WORLDSymposium 2027, taking place January 31–February 4, 2027, in San Diego, California. The Catalyst Award will be presented at the Be The Catalyst event on January 31, the Roscoe O. Brady Award on February 1, and the PAL Award on February 2. The meeting happens only once a year and will convene global experts for five days of scientific sessions, poster presentations, and collaborative discussions to drive progress in lysosomal disease research and care.
Early registration rates end December 18, 2026, and the hotel room block is almost sold out. Attendees are encouraged to register and book now. Learn more and register at worldsymposia.org.
About WORLDSymposium
WORLDSymposium™ (We’re Organizing Research on Lysosomal Diseases) is an annual global medical education conference focused on lysosomal and related diseases. Now in its 23rd year, the meeting brings together more than 2,000 researchers, clinicians, patient advocates, and industry professionals from over 50 countries to exchange knowledge and advance the field. The 2027 Annual Scientific Meeting will take place January 31–February 4, 2027, at the Manchester Grand Hyatt in San Diego, California.
Jena Dunham
WORLDSymposium c/o Etherio Group
Visit us on social media:
LinkedIn
Facebook
YouTube
X
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
![]()
Media gallery
